New research out of Australia identifies cannabis as a potential weapon against antibiotic-resistant bacteria.
Almost unnoticed among the multitude of presentations made during ASM Microbe—the annual meeting of the American Society for Microbiology, which ended Monday in San Francisco—was research presented Sunday out of Australia indicating the “surprising” effectiveness of cannabis as a powerful antibiotic. Mark Blaskovich, senior research chemist at the University of Queensland’s Institute for Molecular Bioscience’s […]
Corteva Agriscience rings in the NYSE while Evogene’s Canonic targets medical cannabis.
As Corteva Agriscience rang in today’s session of the New York Stock Exchange, celebrating its independence from DowDupont, I couldn’t help but think about Big Ag’s flirtation with cannabis, especially after CEO Jim Collins referred to Corteva as “a new kind of agriculture company.”